External demand for the Sputnik V vaccine continues to increase, but the strategy to spread production around the world is being a problem for Russia.
A Sputnik V, a Russian vaccine against covid-19 with 91.6% efficacy, has surprised the whole world. According to the Express, there are already more than 50 countries that want the vaccine, but the high demand is starting to cause distribution problems.
As Russia has a limited capacity to produce Sputnik V, the Russian Direct Investment Fund (RDIF), the state fund that controls the distribution of the vaccine, is looking close agreements with countries where the pharmaceutical industry is most developed.
The agreements include clauses that allow Russia to receive millions of doses of its own vaccine.
THE Financial Times advances that RDIF signed production contracts with 15 companies in ten different countries, for a total of 1.4 billion doses. Some of the countries – such as China, India or South Korea – will produce Sputnik V to export it, while others – such as Brazil and Serbia – will only have to worry about the domestic market.
This solution “solves the problem of large-scale production, while offering local availability”, exclaimed Cyrillic Dmitriev, head of RDIF.
Even so, the solution is not perfect, since the vaccine is thus at the mercy of a “vast network” of “private subcontracted companies”, which may slow down the process. Some companies have guaranteed Financial Times what will take months until they can produce the Sputnik V at maximum strength.
The factories in Brazil and India are responsible for producing more than half of the doses foreseen by the RDIF, but said in the morning that the production of these doses has not yet started.
Another example is GL Rapha, the South Korean manufacturer dedicated only to exports, which admitted not being able to fulfill the agreement you did with RDIF – 150 million doses in one year. In the face of incapacity, she was forced to subcontract production to another company, in addition to having already expanded her own facilities.